Indeed, several clinical studies targeting PPARγ have been executed recently to treat advanced lung cancer patients since many preclinical lung cancer studies have proposed the anti-inflammatory function and therapeutic potential of PPARγ for treating lung cancer [7, 34, 35, 38, 39]. Here, PPARG is linked to lung carcinoma.